← Eichor
Study identifier: NCT06863727 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Beijing Longitudinal Disability Survey in Community Elderly

Condition: Ageing · Disability · Cognitive Impairment  ·  Sponsor: Xuanwu Hospital, Beijing

PhaseN/A
Planned participants1962
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this observational study is to establish the prospective cohort of the Beijing Longitudinal Disability Survey in Community Elderly (BLINDSCE) to explore the high-risk factors and preventive interventions for disability and cognitive impairment among community-dwelling adults aged 65 years and over. The main question it aims to answer is: * What are the high-risk factors able to predict the incidence and advance of disability and cognitive impairment in community-dwelling adults aged 65 years and over? * What are the categories of function and cognitive performance trajectory in community-dwelling adults aged 65 years and over?

This description comes directly from the study's public registry record.

Talk to the study team

Yansu Guo, Ph.D  ·  0086031183973736  ·  gys188@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Xuanwu Hospital, Capital Medical UniversityBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06863727